Priority claimed from 24/04/2020; Application No. : 88886693 ;United States of America
Goods or services claimed
IR DIVISION Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; pharmaceutical preparations that modulate rna expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; gene therapy products, namely, gene delivery pharmaceuticals; pharmaceutical preparations for gene therapy, gene editing, and genome editing; gene therapy products for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; viruses, viral vectors and viral constructs, all of the foregoing used as delivery agents, for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disord
Similar marks in class 5, same issue
- Priority claimed from 20/11/2020; Application No. : 90333105 ;United States of America similar · [International Registration No. : 1580323]
- Priority claimed from 20/11/2020; Application No. : 90333097 ;United States of America similar · [International Registration No. : 1580367]
- ELTULVY Priority claimed from 22/03/2021; Application No. : 90593754 ;United States of America similar · Bioverativ Therapeutics Inc.
- Priority claimed from 26/03/2021; Application No. : 90606383 ;United States of America similar · [International Registration No. : 1629561]
- ENMAJU Priority claimed from 14/05/2021; Application No. : 90712401 ;United States of America similar · Johnson & Johnson
- SOTYKTU Priority claimed from 18/05/2021; Application No. : 90718747 ;United States of America similar · Bristol-Myers Squibb Company
Found by the same matcher that powers Brand Watch: identical, contained, near-spellings and sounds-alike names.
What "advertised" means for Priority claimed from 24/04/2020; Application No. : 88886693 ;United States of America
Advertised is not registered. The Registry examined the application, found no bar (or the applicant overcame the objection), and published it. Registration follows only if no opposition is filed within four months, or if an opposition fails. Until the certificate issues, the applicant may use ™ but not ®. Our guide to trademark status meanings explains each stage, and how long registration takes gives realistic timelines.
Source and corrections. Details are reproduced as advertised by the Registrar of Trade Marks in the Trade Marks Journal (a public record) and may contain errors of transcription. Applicants may ask for a correction or removal of their entry by writing to mehak@trademarkindia.pro. This page is information, not legal advice and not a solicitation.